Citius Pharmaceuticals, Inc.

Healthcare · Biotechnology · United States

Last price 0.5231 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 14.36M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company’s late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and Nove...